Your browser doesn't support javascript.
loading
Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact.
Cho, Sung Min; Kim, Yonghyo; Jung, Yooju; Ko, Minjeong; Marko-Varga, Gyorgy; Kwon, Ho Jeong.
  • Cho SM; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
  • Kim Y; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
  • Jung Y; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, BMC D13, 221 84 Lund, Sweden.
  • Ko M; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
  • Marko-Varga G; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
  • Kwon HJ; Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
J Med Chem ; 64(21): 15858-15867, 2021 11 11.
Article en En | MEDLINE | ID: mdl-34730352

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Inhibidores de la Angiogénesis / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Inhibidores de la Angiogénesis / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article